Syndax Pharmaceuticals SNDX Allowance for credit losses
Allowance for credit losses at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ProvisionForOtherCreditLosses.
The official record: Syndax Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's allowance for credit losses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Syndax Pharmaceuticals's allowance for credit losses?
- Syndax Pharmaceuticals (SNDX) reported allowance for credit losses of $916.75K in Q4 2025.
- What does allowance for credit losses mean?
- This represents the estimated expense recognized to account for potential uncollectible receivables or other financial assets. It serves as a buffer against credit risk and reflects management's assessment of counterparty default probability.